Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Getting Worse

I guess it's all relative. I should have said there's not enough demand to make us retail shareholders any money anytime soon.

If MMPs are as important as we think they are, a 3 cent drop and a 2 cent gain is a bit meaningless.

I think Head meant the PR didn't do anything for the SP - and I don't think it was meant to. I think the PR is part of the legal posturing process as you've alluded to.

This is a tough stock to be in, so much potential but a lot of waiting.

Share
New Message
Please login to post a reply